• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盲法对试验结果的影响:一项系统评价与荟萃分析。

The impact of blinding on trial results: A systematic review and meta-analysis.

作者信息

Pitre Tyler, Kirsh Sarah, Jassal Tanvir, Anderson Mason, Padoan Adelia, Xiang Alexander, Mah Jasmine, Zeraatkar Dena

机构信息

Department of Medicine McMaster University Hamilton Ontario Canada.

Department of Anesthesia McMaster University Hamilton Ontario Canada.

出版信息

Cochrane Evid Synth Methods. 2023 Jun 20;1(4):e12015. doi: 10.1002/cesm.12015. eCollection 2023 Jun.

DOI:10.1002/cesm.12015
PMID:40475370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11795910/
Abstract

BACKGROUND

Blinding-the concealment of the arm to which participants have been randomized-is an important consideration for assessing the risk of bias of randomized trials. A growing body of evidence has, however, yielded inconsistent results on whether trials without blinding produce biased findings.

OBJECTIVE

To conduct a systematic review and meta-analysis of the evidence addressing whether trials with and without blinding produce different results.

METHODS

We searched MEDLINE, EMBASE, Cochrane Reviews, JBI EBP, and Web of Science, from inception to May 2022, for studies comparing the results of trials with and without blinding. Pairs of reviewers, working independently and in duplicate, reviewed search results for eligible studies and extracted data. We pooled the results of studies comparing trials with and without blinding of patients, healthcare providers/investigators, and outcome assessors/adjudicators using frequentist random-effects meta-analyses. We coded study results such that a ratio of odds ratio < 1 and difference in standardized mean difference < 0 indicate that trials without blinding overestimate the beneficial effects of treatments.

RESULTS

We identified 47 eligible studies. For dichotomous outcomes, we found low certainty evidence that trials without blinding of patients and healthcare providers and trials without blinding of patients may slightly overestimate the beneficial effects of treatments. We found moderate certainty evidence that trials without blinding of outcome assessors overestimate the beneficial effects of treatments. For continuous outcomes, we found low certainty evidence that trials without blinding of patients and healthcare providers may overestimate the beneficial effects of treatments. We found moderate certainty evidence that trials without blinding of outcome assessors/adjudicators probably overestimate the beneficial effects of treatments.

CONCLUSION

Our systematic review and meta-analysis suggest that blinding may influence trial results in select situations-although the findings are of low certainty and the magnitude of effect is modest. In the absence of high-certainty evidence suggesting that trials with and without blinding produce similar results, investigators should be cautious about interpreting the results of trials without blinding.

摘要

背景

设盲——对参与者被随机分配至的组别进行隐藏——是评估随机试验偏倚风险时的一个重要考量因素。然而,越来越多的证据对于未设盲的试验是否会产生有偏倚的结果给出了不一致的结论。

目的

对有关设盲和未设盲的试验是否产生不同结果的证据进行系统评价和荟萃分析。

方法

我们检索了MEDLINE、EMBASE、Cochrane系统评价、JBI循证卫生保健数据库和科学网,检索时间从各数据库建库至2022年5月,以查找比较设盲和未设盲试验结果的研究。由两组评审员独立且重复地对检索结果进行评审,以筛选出符合条件的研究并提取数据。我们使用频率学派随机效应荟萃分析对比较患者、医疗保健提供者/研究者以及结局评估者/裁决者设盲和未设盲试验结果的研究结果进行汇总。我们对研究结果进行编码,使得优势比的比值<1以及标准化均数差的差值<0表明未设盲的试验高估了治疗的有益效果。

结果

我们确定了47项符合条件的研究。对于二分结局,我们发现低确定性证据表明,患者和医疗保健提供者未设盲的试验以及患者未设盲的试验可能会略微高估治疗的有益效果。我们发现中度确定性证据表明,结局评估者未设盲的试验高估了治疗的有益效果。对于连续性结局,我们发现低确定性证据表明,患者和医疗保健提供者未设盲的试验可能会高估治疗的有益效果。我们发现中度确定性证据表明,结局评估者/裁决者未设盲的试验可能高估了治疗的有益效果。

结论

我们的系统评价和荟萃分析表明,设盲可能在某些情况下影响试验结果——尽管研究结果的确定性较低且效应量较小。在缺乏高确定性证据表明设盲和未设盲的试验产生相似结果的情况下,研究人员在解释未设盲试验的结果时应谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3891/11795910/cd51b9fc08e4/CESM-1-e12015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3891/11795910/0746e913305f/CESM-1-e12015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3891/11795910/cd51b9fc08e4/CESM-1-e12015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3891/11795910/0746e913305f/CESM-1-e12015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3891/11795910/cd51b9fc08e4/CESM-1-e12015-g002.jpg

相似文献

1
The impact of blinding on trial results: A systematic review and meta-analysis.盲法对试验结果的影响:一项系统评价与荟萃分析。
Cochrane Evid Synth Methods. 2023 Jun 20;1(4):e12015. doi: 10.1002/cesm.12015. eCollection 2023 Jun.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors.来自元流行病学研究的有力证据表明,在未能优化随机化以及使患者和结果评估者保持盲态的随机试验中,效应被高估了。
J Clin Epidemiol. 2024 Jan;165:111211. doi: 10.1016/j.jclinepi.2023.11.001. Epub 2023 Nov 7.
4
Antibiotics for secondary prevention of coronary heart disease.用于冠心病二级预防的抗生素。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD003610. doi: 10.1002/14651858.CD003610.pub4.
5
Topical treatment for facial burns.面部烧伤的局部治疗。
Cochrane Database Syst Rev. 2020 Jul 29;7(7):CD008058. doi: 10.1002/14651858.CD008058.pub3.
6
Alcoholics Anonymous and other 12-step programs for alcohol use disorder.戒酒互助会及其他针对酒精使用障碍的12步康复计划。
Cochrane Database Syst Rev. 2020 Mar 11;3(3):CD012880. doi: 10.1002/14651858.CD012880.pub2.
7
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.一线治疗成人晚期肾细胞癌:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013798. doi: 10.1002/14651858.CD013798.pub2.
8
Cerebrolysin for acute ischaemic stroke.脑活素治疗急性缺血性脑卒中。
Cochrane Database Syst Rev. 2023 Oct 11;10(10):CD007026. doi: 10.1002/14651858.CD007026.pub7.
9
Psychosocial interventions for preventing and treating depression in dialysis patients.用于预防和治疗透析患者抑郁症的心理社会干预措施。
Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3.
10
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.

本文引用的文献

1
Impact of Allocation Concealment and Blinding in Trials Addressing Treatments for COVID-19: A Methods Study.评估 COVID-19 治疗方法的试验中分配隐藏和盲法的影响:一项方法学研究。
Am J Epidemiol. 2023 Oct 10;192(10):1678-1687. doi: 10.1093/aje/kwad131.
2
GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach.GRADE指南34:使用最低限度情境化方法对不精确性进行评级的更新。
J Clin Epidemiol. 2022 Oct;150:216-224. doi: 10.1016/j.jclinepi.2022.07.014. Epub 2022 Aug 4.
3
Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics.
观察性证据对假定风险和保护因素的有效性:对 57 个主题的 3744 项荟萃分析的评估。
BMC Med. 2021 Jul 6;19(1):157. doi: 10.1186/s12916-021-02020-6.
4
Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study.缺乏盲法与重症监护随机对照试验死亡率的相关性:一项荟萃流行病学研究。
Crit Care Med. 2021 Oct 1;49(10):1800-1811. doi: 10.1097/CCM.0000000000005065.
5
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
6
A meta-epidemiological study of bias in randomized clinical trials of open and laparoscopic surgery.一项关于开放性和腹腔镜手术随机临床试验中偏倚的荟萃流行病学研究。
Br J Surg. 2021 May 27;108(5):477-483. doi: 10.1093/bjs/znab035.
7
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials.局部研究者对 2 期肿瘤试验的总体缓解率的估计明显高于盲态独立中心评估。
J Clin Pharmacol. 2021 Jun;61(6):810-819. doi: 10.1002/jcph.1790. Epub 2020 Dec 15.
8
Increasing operational and scientific efficiency in clinical trials.提高临床试验的运营和科研效率。
Br J Cancer. 2020 Oct;123(8):1207-1208. doi: 10.1038/s41416-020-0990-8. Epub 2020 Jul 21.
9
Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.随机临床试验中盲法对估计治疗效果的影响:meta 流行病学研究。
BMJ. 2020 Jan 21;368:l6802. doi: 10.1136/bmj.l6802.
10
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.系统评价中不进行荟萃分析的综合 (SWiM):报告指南。
BMJ. 2020 Jan 16;368:l6890. doi: 10.1136/bmj.l6890.